Medical Marijuana

The Missouri State Medical Association opposes the three “medical” marijuana ballot questions that will be offered to Missouri voters in November 2018. MSMA acknowledges there are a limited number of patients who may receive limited relief from minor pain and nausea, but numerous studies have identified negative health effects for a large number of diagnoses.  ​Until the DEA reclassifies marijuana to allow extensive scientific research, MSMA remains concerned Missourians will be gambling with their health using an unregulated drug.
​Read MSMA's Aug. 17, 2018, statement on medical marijuana.

​Contact:  Jeff Howell
​800-869-6762
MSMA General Counsel and 
Director of Governmental Relations

---

MSMA's Medical Marijuana Policy

• MSMA believes there is evidence that suggests marijuana and its related derivatives may have therapeutic benefits for patients with certain medical conditions.  As such, MSMA calls on the Food and Drug Administration and the Drug Enforcement Administration to promptly revise marijuana’s current classification as a Schedule I controlled substance in order to facilitate evidence-based, scientifically-valid clinical research to evaluate its efficacy and safety. (2017)

AMA Marijuana/Cannabis Policies

• Selected AMA Policies
• AMA Council on Science and Public Health Report #5​

---

Missouri's Ballot Measures on Medical Marijuana

---

From Missouri Medicine - Perspective and Science Download PDF

• Why Marijuana Will Not Fix the Opioid Epidemic
• Hemp and Cannabidiol 
• Poisoning, Overdoses, Toxic Exposures Synthetic Cannabinoid 
• Marijuana for Pain
• Medicinal Recreational Marijuana Review of Literature
• Reefer Madness: Legal or Medicinal Marijuana
• Legalization Decriminalization Medicinal Use of Cannabis

---